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Sulfadoxine-resistant Plasmodium falciparum under-
mines	 malaria	 prevention	 with	 sulfadoxine/pyrimethamine.	
Parasites	 with	 a	 highly	 resistant	 mutant	 dihydropteroate	
synthase	 (dhps)	haplotype	have	 recently	emerged	 in	east-
ern	Africa;	 they	negated	preventive	benefits	of	sulfadoxine/
pyrimethamine, and might exacerbate placental malaria. We 
explored emerging lineages of dhps mutant haplotypes in 
Malawi,	the	Democratic	Republic	of	the	Congo,	and	Tanza-
nia	by	using	analyses	of	genetic	microsatellites	flanking	the	
dhps locus. In Malawi, a triple-mutant dhps SGEG	(mutant	
amino	 acids	 are	 underlined)	 haplotype	 emerged	 in	 2010	
that was closely related to pre-existing double-mutant SGEA 
haplotypes, suggesting local origination in Malawi. When we 
compared mutant strains with parasites from the Democratic 
Republic	of	the	Congo	and	Tanzania	by	multiple	independent	
analyses, we found that SGEG parasites were partitioned 
into	separate	lineages	by	country.	These	findings	support	a	
model of local origination of SGEG dhps haplotypes, rather 
than geographic diffusion, and have implications for investi-
gations of emergence and effects of parasite drug resistance.
Antimalarial drug resistance threatens to undermine ef-forts to control Plasmodium falciparum malaria. In 
sub-Saharan Africa, P. falciparum resistance to sulfadox-
ine/pyrimethamine (SP) is widespread, as shown by clinical 
treatment failures and the prevalence of molecular markers 
of drug resistance (1). Despite these findings, SP remains a 
major tool for malaria control when administered as a partner 
drug with artemisinins and as intermittent preventive therapy 
in infants (IPTi), children, and pregnant women (IPTp). Of 
these SP-based interventions, IPTi with SP is safe and effec-
tive (2), IPT in children receiving SP and amodiaquine has 
shown promise in western Africa (3,4), and IPTp-SP is used 
widely across sub-Saharan Africa. All 3 policies are recom-
mended by the World Health Organization for many settings 
in Africa (5–7). Spread of sulfadoxine-resistant parasites will 
compromise the effectiveness of these programs.
IPTp-SP has been adopted most broadly; however, 
its efficacy appears to be decreasing in areas with increas-
ing parasite resistance to SP (8,9). Reduced susceptibil-
ity to sulfadoxine is conferred mainly by nonsynonymous 
substitutions at codons 436, 437, 540, and 581 of the P. 
falciparum dihydropteroate synthase (dhps) gene that en-
codes the enzymatic target of sulfadoxine (10). Parasites 
with mutant dhps haplotypes are restricted to sub-Saharan 
Africa, and parasites with the A437G, K540E, and A581G 
mutations (mutant amino acids are underlined), which are 
known as dhps triple mutants (haplotype SGEG across co-
dons 436, 437, 540, and 581), have been limited to eastern 
Africa. In sites in Tanzania in which the SGEG haplotype 
is prevalent, IPTp-SP does not appear to improve birth out-
comes (9), and IPTi with SP is not effective (11).
In addition, recent evidence suggests that IPTp-SP 
might exacerbate placental malaria when women are 
Independent Lineages of  
Highly Sulfadoxine-Resistant  
Plasmodium falciparum Haplotypes, 
Eastern Africa
Steve M. Taylor, Alejandro L. Antonia,1 Whitney E. Harrington, Morgan M. Goheen, Victor Mwapasa, 
Ebbie Chaluluka, Michal Fried, Edward Kabyemela, Mwayi Madanitsa, Carole Khairallah,  
Linda Kalilani-Phiri, Antoinette K. Tshefu, Stephen J. Rogerson, Feiko O. ter Kuile,  
Patrick E. Duffy, and Steven R. Meshnick
Author	 affiliations:	 Duke	 University	 Medical	 Center,	 Durham,	
North	 Carolina,	 USA	 (S.M.	 Taylor);	 University	 of	 North	 Carolina,	
Chapel	Hill,	North	Carolina,	USA	(S.M.	Taylor,	A.L.	Antonia,	M.M.	
Goheen,	S.R.	Meshnick);	Seattle	Children’s	Hospital/University	of	 
Washington	School	of	Medicine,	Seattle,	Washington,	USA	(W.E.	
Harrington);	College	of	Medicine,	Blantyre,	Malawi	 (V.	Mwapasa,	
E.	Chaluluka,	M.	Madanitsa,	 L.	 Kalilani-Phiri);	 National	 Institutes	
of	Health,	Bethesda,	Maryland,	USA	(M.	Fried.	P.E.	Duffy);	Seattle	
Biomedical	Research	 Institute,	Seattle	 (E.	Kabyemela);	Liverpool	
School	 of	 Tropical	 Medicine,	 Liverpool,	 UK	 (C.	 Khairallah,	 F.O.	 
ter	Kuile);	University	of	Kinshasa,	Kinshasha,	Democratic	Republic	
of	 the	Congo	 (A.K.	Tshefu);	University	of	Melbourne,	Melbourne,	
Victoria,	Australia	 (S.J.	Rogerson);	and	University	of	Amsterdam,	
Amsterdam,	the	Netherlands	(F.O.	ter	Kuile)
DOI:	http://dx.doi.org/10.3201/eid2007.131720
1Current	affiliation:	Duke	University	School	of	Medicine,	Durham,	
North	Carolina,	USA.
	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	20,	No.	7,	July	2014	 1141
infected with parasites that have the A581G mutation in 
dhps (12), which suggests that these parasites manifest 
increased pathogenicity under drug pressure. In contrast, 
there was no evidence of pathogenicity caused by A581G-
bearing parasites in Malawi, and SP retained some efficacy 
in preventing illness caused by malaria during pregnancy 
(J. Gutman et al., unpub. data). These contrasting effects of 
this resistant parasite haplotype suggest that effects of the 
A581G mutation might vary among populations. However, 
if parasites from northern Tanzania dessiminate, parasites 
bearing the dhps A581G mutation could broadly under-
mine malaria control efforts in infants and pregnant women 
in Africa.
Because of these findings, molecular surveillance for 
this mutation is critical to assess the durability of SP for 
malaria prevention. Genetic studies have shown that mu-
tations conferring resistance to chloroquine (13) and pyri-
methamine (14) have arisen only a few times and then dif-
fused across regions and continents. In contrast, resistance 
to sulfadoxine appears to have arisen independently in mul-
tiple locations (15,16), after originating only in Southeast 
Asia, followed by export to Africa (supported by global 
survey findings) (17). Efforts to prevent dissemination of 
the A581G mutation hinge on understanding whether the 
mutation arises de novo or is spread among locations.
To better understand the emergence of sulfadoxine-
resistant P. falciparum in eastern Africa, we first used 
microsatellite genotyping to study the emergence of para-
sites harboring dhps haplotypes with the A581G mutation 
in a longitudinal study in Malawi during 1997–2010 (8). 
We then compared the genetic background of these triple-
mutant SGEG parasites in Malawi in a cross-sectional 
analysis with mutant parasite haplotypes from Tanzania 
and the Democratic Republic of the Congo (DRC). In 
these 2 investigations, we hypothesized that extant SGEA 
haplotypes in Malawi would share a genetic lineage with 
recently emerged SGEG haplotypes, and that these SGEG 
haplotypes from Malawi would represent a distinct lineage 
compared with SGEG haplotypes from other settings in 
eastern Africa.
Methods
Ethics
All participants provided written or oral informed con-
sent. Ethical approval for project activities was provided by 
the review boards of the Malawi Health Sciences Research 
Committee, the University of Malawi College of Medi-
cine Research Ethics Committee, the Liverpool School of 
Tropical Medicine, Macro International, the School of Pub-
lic Health of the University of Kinshasa, the International 
Clinical Studies Review Committee of the National Insti-
tutes of Health, the Seattle Biomedical Research Institute, 
the Tanzanian National Institute for Medical Research, and 
the University of North Carolina.
Sample Collection
Parasites from Malawi were obtained from peripheral 
blood of women who delivered children at Queen Elizabeth 
Central Hospital in Blantyre, Malawi, during 1997–2005 
(18). In 2010, consecutive women who delivered children 
at study sites near Blantyre were offered enrollment into 
an observational study (F.O. ter Kuile et al., unpub. data). 
Dried blood spots were prepared from maternal peripheral 
and placental blood of enrollees.
Parasites from the DRC were obtained from adults in 
the 2007 Demographic and Health Survey (19). Parasites 
from Tanzania were obtained from placental blood of preg-
nant women delivering at Muheza Designated District Hos-
pital during 2002–2005 (12).
Genotyping Procedures
For parasites from Malawi and DRC, genomic DNA 
was extracted from dried blood spots by using Chelex-100 
or a PureLink 96 DNA Kit (Life Technologies, Grand Is-
land, NY, USA), and P. falciparum was detected by using 
real-time PCR (19). These parasites were genotyped at dhps 
loci by using amplification and Sanger sequencing (18,20), 
and only those with pure A581G genotypes were geno-
typed at microsatellites. For parasites from Tanzania, the 
mutant alleles A437G and K540E are nearly fixed; A581G 
was identified by pyrosequencing (12). We classified para-
sites as having A581G if the mutant allele frequency was 
≥90% within the parasitemia level of the person.
Five microsatellite loci flanking the dhps gene were 
genotyped in all isolates: –2.9 and –0.13 kB upstream, and 
0.03, 0.5, and 9 kB downstream of dhps (20). PCR prod-
ucts of amplifications of individual loci were sized on a 310 
Genetic Analyzer (Applied Biosystems, Foster City, CA, 
USA), and allele lengths were scored by using GeneMap-
per v4.1 (Applied Biosystems). In specimens with multiple 
peaks, the major peak was analyzed. All specimens were 
amplified and sized in parallel with genomic DNA from 
P. falciparum isolate 3D7 (American Type Culture Col-
lection, Manassas, VA, USA). These controls were used 
to correct allele lengths to account for batch variability in 
fragment sizing.
Data Analyses
We computed heterozygosity (He) of microsatellite 
loci by using GenAlEx v6.5 (21) to quantify the degree 
of selection on mutant haplotypes. To assess relatedness 
among dhps haplotypes in Malawi during 1997–2010, we 
used GenAlEx to compute ΦPT by analysis of molecular 
variance (AMOVA) with 999 permutations over the whole 
population (22) and the Nei genetic distance (23) among 
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dhps haplotypes and years based on microsatellite profiles. 
We inputted ΦPT values computed by AMOVA into a prin-
cipal coordinates analysis (PCoA) in GenAlEx.
We further characterized these relationships with a 
network analysis. To characterize these relationships, we 
assigned unique haplotypes based on microsatellite profiles 
for the 91 isolates for which we had successfully genotyped 
all microsatellite loci. These unique haplotypes were input-
ted into NETWORK v4.6.1.1 (24,25), and weights were as-
signed to each locus in inverse proportion to the He, of the 
locus, as calculated above.
In cross-sectional analysis of parasite populations from 
eastern Africa defined by location and dhps haplotype, we 
first used GenAlEx to compute pairwise linear genetic dis-
tances and ΦPT (by using AMOVA with 999 permutations 
over the full population) and then used SPAGeDi v1.4 (26) 
to compute pairwise RST (by using jackknifing with 1,000 
permutations). We inputted pairwise tri-distance matrices 
of linear genetic distance, ΦPT, and RST into separate PCoAs 
in GenAlEx. For testing of statistical significance, we con-
sidered a p value of 0.05 as sufficient to reject the null hy-
pothesis and used the Bonferroni correction when comput-
ing multiple comparisons.
We constructed a neighbor-joining (NJ) network to es-
timate a phylogeny of dhps haplotypes circulating in east-
ern Africa. To construct this network, we first computed 
pairwise linear genetic distances among all 193 isolates in 
GenAlEx; this distance matrix was used to compute an un-
rooted NJ tree in PHYLIP v3.67 (27,28), which was com-
puted agnostic to dhps haplotype and geographic location 
and rendered in R v3.0.1. Missing alleles precluded compu-
tation of a median-joining network with NETWORK (on-
line Technical Appendix Table 1, http://wwwnc.cdc.gov/
EID/article/20/7/13-1720-Techapp1.pdf).
We investigated population structure of the dhps hap-
lotypes from these 193 isolates by using STRUCTURE 
v2.3.4, a clustering algorithm designed to infer and assign 
individuals to subpopulations (29). Although it was not 
specifically designed to identify population structure based 
on linked loci, we used STRUCTURE to test our a priori 
hypothesis of distinct subpopulations based on dhps hap-
lotype and location (30). We performed 3 analyses: first, 
of all 193 parasites of all dhps haplotypes; second, of 116 
parasites with any mutant dhps haplotype; and third, of 
32 parasites with only the triple-mutant SGEG dhps hap-
lotype. We performed 5 simulations each at values of K-
estimated populations from 1 to 20, and estimated the true 
K a posteriori by using estimations in STRUCTURE, as 
well as using the method of Evanno et al. (31)
Results
Longitudinal Analyses of Parasites in Malawi
We first tested 114 P. falciparum isolates from Ma-
lawi collected during 1997–2010. We identified 25 wild-
type SAKA parasites, 1 single-mutant SGKA, 68 double-
mutant SGEA, 10 triple-mutant SGEG, and 10 with other 
dhps haplotypes, including AAKA, AGEA, AGKA, and 
SAEA. Among major haplotypes, we observed reductions 
in microsatellite allele mean heterozygosity (He) in para-
sites having double-mutant SGEA (He 0.454, SE 0.076) 
and triple-mutant SGEG dhps haplotypes (He 0.485, SE 
0.134) compared with those from wild-type parasites (He 
0.798, SE 0.064). These findings are consistent with posi-
tive selection on mutant haplotypes, presumably caused by 
sulfadoxine pressure.
Given the recent emergence of triple-mutant SGEG 
haplotype in 2010, we investigated its relationship with the 
double-mutant SGEA haplotype that had become fixed in 
this population by 2005 (32). To quantify genetic related-
ness among years and major dhps haplotypes, we first com-
puted pairwise ΦPT values and Nei genetic distance among 
major dhps haplotypes binned by year. In these analy-
ses, SGEA haplotypes were closely related to each other 
during 1997–2005 (ΦPT values 0.008–0.065, Nei value 
0.016–0.073) and closely related to the SGEG haplotype 
that emerged by 2010 (ΦPT 0.082, Nei value 0.049) (Table). 
We inputted ΦPT estimates into a PCoA to better visualize 
divergence among haplotypes by year. In this analysis, co-
ordinates 1 and 2 explained 96.3% of the variance; SGEA 
haplotypes from all years clustered with SGEG haplotypes 
from 2010, which suggested a shared lineage in Malawi of 
mutant dhps haplotypes during 1997–2010 (online Techni-
cal Appendix Figure 1).
 
Table.	Pairwise	ΦPT values	and	Nei	genetic	distances	among	major	Plasmodium falciparum dhps haplotypes	by	year,	Malawi* 
Haplotype,	year 
SAKA,	
1997–1999 
SAKA,	
2000–2003 
SGEA, 
1997–1999 
SGEA, 
2000–2003 
SGEA, 
2004–2005 SGEA,	2010 SGEG,	2010 
SAKA,	1997–1999  0.251 0.470 0.693 0.818 1.095 1.044 
SAKA,	2000–2003 0  0.362 0.264 0.200 0.350 0.162 
SGEA,	1997–1999 0.249 0.331  0.02 0.073 0.429 0.246 
SGEA, 2000–2003 0.295 0.347 0.008  0.016 0.302 0.096 
SGEA,	2004–2005 0.318 0.404 0.065 0.030  0.300 0.049 
SGEA,	2010 0.299 0.380 0.298 0.243 0.237  0.031 
SGEG,	2010 0.243 0.299 0.202 0.155 0.082 0.015  
*Values	for	dhps haplotypes	are	defined	by	amino	acids	at	codons	436,	437,	540,	and	581.	Mutant	amino	acids	are	underlined	and	in	bold.	Pairwise ΦPT 
values	are	shown	below	the	diagonal;	values	in	bold	have	a	p	value	<0.05	(after	Bonferroni	correction	for	multiple	comparisons)	based	on	999	
permutations.	Nei	unbiased	genetic	distances	are	shown	above	the	diagonal. 
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We further investigated this finding by using network 
analysis. To perform this analysis, we constructed a me-
dian-joining network of wild-type and mutant haplotypes 
by year based on microsatellite profiles (Figure 1). In this 
analysis, we observed clustering of triple-mutant SGEG 
haplotypes from 2010 in a network of double-mutant 
SGEA haplotypes, as well as substantial sharing of mic-
rosatellite profiles among SGEA parasites from different 
years and with SGEG parasites. These 2 observations sug-
gest a shared lineage of evolved mutant dhps haplotypes 
in Malawi.
Cross-sectional Analyses of Parasite Haplotypes  
for Eastern Africa
Clinical consequences of infections with parasites 
bearing the dhps A581G mutation appear to vary among 
study sites in Africa. In Tanzania, these parasites have been 
associated with exacerbation of placental inflammation in 
women who received IPTp (12) and failure of IPTp-SP to 
prevent low birthweight of infants (33). In Malawi, these 
phenomena have not yet been observed. Because of these 
differing effects, we speculated that haplotypes bearing the 
A581G mutation may also differ among sites.
We conducted a cross-sectional analysis of parasites 
from 2 additional cohorts: 1) adults sampled in 2007 from the 
eastern DRC (19), and 2) pregnant women who gave birth 
and were enrolled during 2002–2005 in Muheza, Tanzania 
(12). In total, we compared the genetic relationships among 
193 parasites grouped into 7 parasite populations: wild-type 
(SAKA) isolates from the DRC (n = 53) and Malawi (n = 
24), those bearing double-mutant (SGEA) haplotypes from 
the DRC (n = 17) and Malawi (n = 67), and those bearing 
triple-mutant (SGEG) haplotypes from the DRC (n = 5), Ma-
lawi (n = 10), and Tanzania (n = 17). Fragment lengths are 
shown in online Technical Appendix Table 1.
We quantified divergence of these 7 populations based 
on microsatellite allele lengths by using 3 population ge-
netic metrics: linear genetic distance, ΦPT, and RST. Linear 
genetic distance is a simple Euclidean genetic distance met-
ric, and ΦPT, and RST are variations of Wright F-statistics 
that quantify divergence and estimate its variance (22,34). 
Among SGEG parasites from Malawi and Tanzania, ΦPT 
(0.420, p = 0.001) and RST (0.436, p<0.0001) indicated sig-
nificant divergence after Bonferroni correction for multiple 
comparisons (online Technical Appendix Table 2); ΦPT and 
RST for other pairwise comparisons among SGEG parasites 
from Malawi, the DRC, and Tanzania were not significant 
but suggested similar divergence (values >0.420).
We visualized the output of each of these metrics with 
separate PCoAs (Figure 2; online Technical Appendix Fig-
ure 2). In the PCoAs of genetic distance, ΦPT, and RST, the 
first 2 coordinates accounted for 89%, 94.3%, and 96% of 
variance in values, respectively. In each PCoA plot, SGEG 
parasites from Malawi, the DRC, and Tanzania were con-
sistently distant from each other in the 2 plotted dimen-
sions, and other relationships among populations were 
variable. These analyses suggested divergence of SGEG 
haplotypes in Malawi, Tanzania, and the DRC.
Figure	 1.	 Genetic	 relatedness	
of Plasmodium falciparum 
dihydropteroate	 synthase	 (dhps)	
haplotypes from Malawi over 
time based on median-joining 
network	 of	microsatellite	 profiles.	
Median-joining network was 
calculated based on microsatellite 
profiles	 for	 91	 parasites	 with	 full	
genotype	 data.	 Colors	 indicate	
year and dhps haplotype, nodes 
are proportional to the number of 
parasites with that microsatellite 
profile,	red	nodes	are	hypothetical	
profiles	 inserted	 by	 the	 program	
to calculate a parsimonious 
network, and branch lengths are 
arbitrary.	 Values	 were	 computed	
in	 NETWORK	 v4.6.1.1.	 (24,25).	
The dhps	haplotypes	are	defined	
by	 amino	 acids	 at	 codons	 436,	
437,	540,	and	581.	Mutant	amino	
acids are underlined and in bold. 
SAKA,	 wild-type;	 SGEA and 
SGEG, mutants.
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To further investigate this apparent divergence of 
SGEG haplotypes, we computed an NJ network based on 
pairwise linear genetic distances among all 193 isolates. 
This phylogenetic analysis, which was computed agnos-
tic to country and dhps haplotype, clustered all 17 SGEG 
parasites from Tanzania distinctly from 8 of the 10 SGEG 
parasites from Malawi; haplotypes in these clusters were 
also distinct from 3 of the 5 SGEG parasites from the DRC 
(Figure 3). A large number of SGEA parasites from Malawi 
also clustered closely with SGEG parasites from Tanzania, 
which suggested some shared lineage. This inferred phy-
logeny further suggests that triple-mutant dhps haplotypes 
from Tanzania and Malawi bearing the A581G substitution 
have arisen independently.
To further investigate this partition of dhps lineages, 
we performed an analysis of population structure. The first 
analysis of all 193 wild-type and mutant parasites parti-
tioned only dhps haplotypes into mutant and wild-type, ir-
respective of geographic location. When restricted to the 
116 parasites with mutant dhps haplotypes, the program 
partitioned the dataset into 3 clusters with 99.9% poste-
rior probability; these 3 clusters directly corresponded to 
geographic location but were irrespective of dhps haplo-
type, which suggested separate lineages of mutant dhps 
haplotypes in Malawi, the DRC, and Tanzania (Figure 4, 
panel A). In an analysis restricted to the 32 parasites bear-
ing the SGEG dhps haplotype, 2 population clusters were 
identified with the highest posterior probability. All SGEG 
parasites from Tanzania were assigned to 1 cluster, and 
SGEG parasites from Malawi and the DRC were assigned 
to a second cluster (Figure 4, panel B). These analyses fur-
ther suggest that lineages of triple-mutant dhps haplotypes 
bearing the A581G mutation from Malawi and Tanzania 
are divergent.
Discussion
In these longitudinal and cross-sectional analyses of 
P. falciparum haplotypes from eastern Africa that were as-
sociated with high-level parasite sulfadoxine resistance, we 
demonstrated emergence of a distinct lineage of triple-mu-
tant dhps haplotypes in Malawi. In comparative analyses, 
these dhps triple-mutant SGEG haplotypes from Malawi 
were strongly divergent from haplotypes collected in north-
ern Tanzania, which suggested independent emergence of 
this drug-resistant haplotype in these 2 settings in eastern 
Africa. This parasite haplotype appears to undermine effi-
cacy of SP in preventing P. falciparum infection in infants 
and pregnant women (9,11); its spread could undermine 
current and nascent malaria control programs that are pred-
icated on SP efficacy. To guide malaria control policies that 
use SP, surveillance of molecular markers of P. falciparum 
drug resistance need to be complemented by clinical stud-
ies of effects of these parasite mutations on maternal and 
infant birth outcomes.
Our data indicate that triple-mutant SGEG dhps hap-
lotypes from Malawi, Tanzania, and the DRC represent 
distinct lineages. The circumscribed regional distribution 
is well described for single-mutant and double-mutant dhps 
haplotypes across sub-Saharan Africa (15,20), but our study 
describes this phenomenon on a subregional scale with the 
emerging, more highly resistant triple-mutant SGEG hap-
lotype. In our analyses, support for this genetic divergence 
derives from population genetic metrics, including genetic 
distance and F-statistics (online Technical Appendix Table 
2), PCoA (Figure 2; online Technical Appendix Figure 2), 
unsupervised haplotype phylogeny (Figure 3), and inferred 
population structure (Figure 4).
Parasites from Malawi and Tanzania  were most 
consistently partitioned into distinct SGEG lineages and 
showed statistically significant divergence by ΦPT (0.42, 
p = 0.001) and RST (0.436, p<0.0001) (online Technical 
Appendix Table 2), visually apparent partitioning in an 
NJ network (Figure 3) and in PCoA (Figure 2), and as-
signment to separate subpopulations in a probabilistic 
clustering algorithm (Figure 4). In a previous study, dou-
ble-mutant SGEA haplotypes in eastern Africa (including 
Malawi, Tanzania, and eastern DRC) shared a common 
lineage (15). Our study supports this finding for parasites 
from Malawi and the DRC, with closely related SGEA 
parasites identified by ΦPT (0.017, p = 0.228) and RST 
(0.0164, p = 0.4306) (online Technical Appendix Table 
2). Our data suggest that despite this shared double-mutant 
Figure	2.	Principal	coordinates	analyses	of	wild-type	(SAKA)	and	mutant	
(SGEA and SGEG)	Plasmodium falciparum dihydropteroate synthase 
(dhps)	halotypes	from	eastern	Africa	based	on	analysis	of	variance	(RST).	
Pairwise	RST	values	were	computed	with	SPAGeDi	(26)	for	microsatellite	
profiles	 of	 7	 populations	 of	 parasites	 defined	 by	 dhps haplotype and 
location:	 SAKA	 parasites	 from	 Malawi	 (n	 =	 24)	 and	 the	 Democratic	
Republic	of	the	Congo	(DRC)	(n	=	53)	(blue	dots);	SGEA parasites from 
Malawi	(n	=	67)	and	DRC	(n	=	17)	(green	dots);	and	SGEG parasites 
from	DRC	(n	=	5),	Malawi	(n	=	10),	and	Tanzania	(n	=	17)	(yellow	dots).	
These pairwise values were inputted into principal coordinates analyses 
in	GenAlEx	(21),	in	which	coordinates	1	and	2	cumulatively	accounted	for	
96%	of	the	variance.	The	dhps	haplotypes	are	defined	by	amino	acids	at	
codons	436,	437,	540,	and	581.	Mutant	amino	acids	are	underlined	and	
in bold.
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dhps haplotype, the additional A581G mutation has arisen 
independently in different locations in, at least, Malawi 
and Tanzania.
Recent studies of pregnant women have implicated 
parasites bearing the SGEG dhps haplotype with under-
mining the efficacy of IPTp-SP (J. Gutman et al., unpub. 
data, 33) and possibly exacerbating placental infection in 
women who received IPTp-SP (12). Despite these findings, 
results of various studies are inconsistent regarding the ef-
fect of the SGEG haplotype on IPTp-SP. On a population 
level, IPTp-SP appears to retain some efficacy in preventing 
low birthweight in infants in studies in Malawi, where the 
SGEG haplotype is just emerging (35), but not in northern 
Tanzania, where SGEG parasites are more prevalent (9). On 
an individual level, IPTp-SP is less effective at preventing 
peripheral parasitemia at delivery caused by parasites bear-
ing the SGEG haplotype in Malawi (J. Gutman et al., unpub. 
data), but IPTp-SP was implicated as exacerbating placental 
parasite density and inflammation in the presence of SGEG 
parasites in Tanzania (12). These inconsistencies in eco-
logic studies may derive from different frequencies of the 
A581G mutation in parasite populations in the 2 settings.
A second explanation for the differences is that these 
effects might be derived from additional mutations that 
are associated with genotyped loci caused either by differ-
ent genetic backgrounds or linkage disequilibrium. Such 
mutations may be hypothesized to exist in the dhps gene 
itself, in loci which mediate DHPS expression and thereby 
parasite fitness in the presence of drug, or in heretofore 
undescribed mediators of pathogenesis. In areas in which 
parasites bearing the SGEG haplotypes are emerging, stud-
ies of parasite genomics and phenotypes can further inves-
tigate these possibilities.
Our results suggest atypical spread in Africa of para-
site haplotypes conferring sulfadoxine resistance: haplo-
types that confer resistance to chloroquine (13) and py-
rimethamine (14) appear to have limited origins and are 
believed to have spread across Africa largely by gene flow. 
Similarly, a previous global survey of dhps haplotypes sug-
gested that resistant lineages originated in Southeast Asia 
and migrated to Africa (17), although this study did not in-
clude any parasites from Africa with the SGEG dhps hap-
lotype. In contrast, our data support the local origination 
and emergence of this highly resistant haplotype, similar 
to rare resistant dhfr haplotypes (36). This phenomenon 
for dhps has been most clearly described on a fine scale in 
Southeast Asia (16), and our data support a similar process 
in eastern Africa.
This model is further supported by our longitudinal 
sampling and testing of parasite specimens in Malawi 
during 1997–2010. During this period, SGEG haplotypes 
arose after SGEA haplotypes had achieved near fixation. 
Figure	 3.	 Neighbor-joining	 network	
of Plasmodium falciparum wild-type 
(SAKA)	 and	 mutant	 (SGEA and 
SGEG)	 dihydropteroate	 synthase	
(dhps)	 haplotypes,	 eastern	 Africa.	
Pairwise	 linear	 genetic	 distances	
among	 193	 parasite	 isolates	 were	
computed	in	GenAlEx	(21)	inputted	
into	 PHYLIP	 v3.67	 (27,28)	 to	
calculate an unrooted neighbor-
joining	 tree,	 and	 rendered	 in	 R	
v3.0.1	 (http://www.r-project.org/)	
by	 using	 the	 ape	 package.	 For	
visualization, branch lengths were 
uniformly	lengthened	if	not	equal	to	
0. The dhps	haplotypes	are	defined	
by	amino	acids	at	codons	436,	437,	
540,	 and	 581.	Mutant	 amino	 acids	
are	underlined	and	in	bold.	DRC,	the	
Democratic	Republic	of	the	Congo.	
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This observation could have been caused by importa-
tion of a new parasite population bearing the SGEG dhps 
haplotype or by A581G mutation in the existing parasite 
population. Our data suggest that the mutation accounts for 
appearance of the SGEG haplotype because of the close re-
lationship among mutant haplotypes both computationally 
by ΦPT and visually in a median-joining network (Figure 1), 
which suggests that SGEA haplotypes gave rise to SGEG 
haplotypes in Malawi.
What are the implications of our findings for IPTp-
SP? IPTp-SP is still used extensively in settings in eastern 
and southern Africa that have prevalent parasite resistance. 
Failures of IPTp-SP have prompted investigations to define 
the prevalence of the A581G mutation (37) and to more 
closely investigate its potential for modifying the beneficial 
effect of IPTp-SP. Our results have 2 practical implications 
for these investigations. First, these data suggest that the 
SGEG haplotype may arise where a SGEA haplotype is cir-
culating without requiring the importation of a new mutant 
haplotype. Therefore, even in settings without major mi-
gration of parasites, continued use of sulfadoxine or other 
sulfonamides may promote emergence of this haplotype. 
Molecular surveillance is critical for detecting this step. 
Second, given the differing effects of parasites bearing the 
SGEG haplotype on IPTp-SP among settings, it would ap-
pear prudent to supplement molecular surveillance for the 
dhps A581G mutation in areas where it is present by stud-
ies of its effects on pregnant women and their infants and 
other clinical outcomes.
Our study has several limitations. First, the number 
of available parasites bearing the SGEG haplotype is 
limited. These parasites have emerged only recently in 
Africa, precluding a more widespread analysis. Second, 
we did not have SGEA parasites from Tanzania against 
Figure	4.	Predicted	population	structure	of	Plasmodium falciparum	parasites	 from	eastern	Africa	among	 those	with	A)	double-mutant	
(SGEA)	 or	 triple-mutant	 (SGEG)	 dihydropteroate	 synthase	 (dhps)	 haplotypes	 and	 B)	 those	 with	 only	 the	 triple-mutant	 SGEG dhps 
haplotype.	Estimations	of	number	of	populations	and	assignments	of	individual	parasites	to	clusters	were	computed	with	STRUCTURE	
(29,30)	by	using	a	burn-in	period	of	10,000	and	10,000	iterations	and	models	that	assume	no	admixture	and	which	use	prior	information	
related to location because of sparse data and likely subtle structure. Each vertical bar represents an individual parasite, and the color of 
each bar indicates the likelihood of membership in the subpopulation indicated by the color. The dhps	haplotypes	are	defined	by	amino	
acids	at	codons	436,	437,	540,	and	581.	Mutant	amino	acids	are	underlined	and	in	bold.	A)	Analysis	of	116	parasites	from	Malawi,	the	
Democratic	Republic	of	the	Congo	(DRC),	and	Tanzania	with	either	SGEA or SGEG dhps	haplotypes.	The	posterior	probability	was	99.9%	
of	the	existence	of	3	population	clusters	that	are	indicated	by	the	color.	B)	A	similar	analysis	restricted	to	32	parasites	with	only	the	SGEG 
dhps	haplotype	from	Malawi,	DRC,	and	Tanzania.	The	division	into	2	populations	indicated	by	the	color	was	supported	by	a	posterior	
probability	of	41%,	which	is	higher	than	for	those	of	other	a	priori	population	sizes	tested.
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which to compare microsatellite profiles of the SGEG 
parasites. Third, these SGEG parasites were collected in 
different clinical studies in different years; the 2 principal 
populations of parasites were collected from women giv-
ing birth in Malawi and Tanzania during 2002–2010 and 
are therefore quite similar.
These analyses of malaria parasites in eastern Africa 
support a model of local origination and propagation of 
triple-mutant SGEG P. falciparum dhps haplotypes that 
confer high levels of resistance to sulfadoxine. Recent evi-
dence indicates that these haplotypes abrogate the efficacy 
of SP use to prevent malaria among pregnant women and 
their infants in eastern Africa. Integrated clinical and mo-
lecular surveillance for these mutations in parasite popula-
tions is critical to assess the durability of prevention pro-
grams that use SP. These efforts should be complemented 
with ongoing investigations of more effective methods to 
protect vulnerable populations from malaria.
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